Age: 15.0
Sex: F
Vaccine: HIBV
Symptoms: Inappropriate schedule of product administration
Clinical narrative: extra dose of vaccination; inappropriate schedule; This spontaneous report has been received from a lawyer and physician, via a memo and medical records from a case in litigation for quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL) (2302USA008667), concerning a 9-month-old female patient. Her historical conditions included pharyngitis, gastroenteritis, viral syndrome, ear infections, allergic rhinitis, upper respiratory infection, abdominal pain and eczema. Family history of mixed hyperlipidemia. family history included: add/adhs (brother), fibromyalgia (maternal aunt), irritable bowel syndrome (mother and maternal grandmother), allergies (mother).  On 07-SEP-2001, the patient was vaccinated with haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as HiB) (dose, route of vaccination, vaccination site, lot # and expiration date were not reported) for prophylaxis. On the same day, the pt was also vaccinated with diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTaP), pneumococcal conjugate vaccine and polio unspecified vaccine.  On 07-NOV-2001, the pt was vaccinated with the second dose of haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as HiB) (dose, route of administration, vaccination site, lot # and expiration date were not provided) for prophylaxis. On the same day, the pt was also vaccinated with diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTaP), pneumococcal conjugate vaccine and polio unspecified vaccine.  On 04-JAN-2002, the pt was vaccinated with the third dose of haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as HiB) (dose, route of administration, vaccination site, lot # and expiration date were not provided) for prophylaxis (inappropriate schedule of product administration). On the same day, the pt was also vaccinated with diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTaP) and pneumococcal conjugate vaccine. On 08-OCT-2002, the pt was vaccinated with the fourth dose of haemophilus b conjugate vaccine (Meningococcal Protein Conjugate) (manufacturer unknown) (reported as HiB) (dose, route of administration, vaccination site, lot # and expiration date were not provided) for prophylaxis (extra dose administered). Other vaccines included: quadrivalent human papillomavirus (HPV) (types 6,11,16,18) recomb. vaccine (GARDASIL), hepatitis A vaccine, inactivated (VAQTA), hepatitis b vaccine (recombinant) (manufacturer unknown) (reported as Hep B, unspecified), measles vaccine, mumps vaccine, rubella vaccine (MMR), meningococcal vaccine b rfhbp/nada/nhba omv (BEXSERO), meningococcal vaccine a/c/y/w conj (DIP TOX) (MENACTRA), pneumococcal conjugate vaccine, polio unspecified vaccine, diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (Tdap) and varicella virus vaccine live (Oka/Merck) (VARIVAX).  This is one of the three reports received from the same reporter, concerning the same patient.